BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

10141 related articles for article (PubMed ID: 19852120)

  • 21. Mohs micrographic surgery: a synopsis.
    Stone JL
    Hawaii Med J; 1993 May; 52(5):134-9. PubMed ID: 8320092
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Innovative 19-minute rapid cytokeratin immunostaining of nonmelanoma skin cancer in Mohs micrographic surgery.
    Cherpelis BS; Turner L; Ladd S; Glass LF; Fenske NA
    Dermatol Surg; 2009 Jul; 35(7):1050-6. PubMed ID: 19469800
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Who should have Mohs micrographic surgery?
    Perkins W
    Curr Opin Otolaryngol Head Neck Surg; 2010 Aug; 18(4):283-9. PubMed ID: 20613530
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Cost analysis of Mohs micrographic surgery in high-risk facial basal cell carcinoma].
    Blázquez-Sánchez N; de Troya-Martín M; Frieyro-Elicegui M; Fúnez-Liébana R; Martín-Márquez L; Rivas-Ruiz F
    Actas Dermosifiliogr; 2010 Sep; 101(7):622-8. PubMed ID: 20858388
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mohs micrographic surgery for the treatment of difficult skin cancers.
    Skouge JW
    Md Med J; 1997; 46(5):231-7. PubMed ID: 9159052
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mohs micrographic surgery in the treatment of rare aggressive cutaneous tumors: the Geisinger experience.
    Thomas CJ; Wood GC; Marks VJ
    Dermatol Surg; 2007 Mar; 33(3):333-9. PubMed ID: 17338692
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost-effectiveness of Mohs micrographic surgery vs surgical excision for basal cell carcinoma of the face.
    Otley CC
    Arch Dermatol; 2006 Sep; 142(9):1235; author reply 1235-6. PubMed ID: 16983019
    [No Abstract]   [Full Text] [Related]  

  • 28. Consensus for nonmelanoma skin cancer treatment: basal cell carcinoma, including a cost analysis of treatment methods.
    Kauvar AN; Cronin T; Roenigk R; Hruza G; Bennett R;
    Dermatol Surg; 2015 May; 41(5):550-71. PubMed ID: 25868035
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mohs micrographic surgery for the treatment of malignant melanoma.
    Whalen J; Leone D
    Clin Dermatol; 2009; 27(6):597-602. PubMed ID: 19880047
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Complete treatment of basal cell carcinoma; cost effectiveness of Mohs micrographic surgery versus conventional excision].
    Muche JM; van Rengen A; Mosterd K
    Ned Tijdschr Geneeskd; 2017; 161():D1549. PubMed ID: 29303086
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Two-stage excision of extensive cutaneous carcinoma of the face. A retrospective study of 80 patients].
    Arfi C; Bureau B; Beauvillain C; Nguyen JM; Stalder JF; Litoux P
    Ann Dermatol Venereol; 1995; 122(11-12):764-8. PubMed ID: 8729820
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mohs micrographic surgery concordance between Mohs surgeons and dermatopathologists.
    Semkova K; Mallipeddi R; Robson A; Palamaras I
    Dermatol Surg; 2013 Nov; 39(11):1648-52. PubMed ID: 24581313
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cutaneous squamous cell carcinoma treated with Mohs micrographic surgery in Australia I. Experience over 10 years.
    Leibovitch I; Huilgol SC; Selva D; Hill D; Richards S; Paver R
    J Am Acad Dermatol; 2005 Aug; 53(2):253-60. PubMed ID: 16021120
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Wide excision or Mohs micrographic surgery for the treatment of primary dermatofibrosarcoma protuberans.
    Meguerditchian AN; Wang J; Lema B; Kraybill WG; Zeitouni NC; Kane JM
    Am J Clin Oncol; 2010 Jun; 33(3):300-3. PubMed ID: 19858696
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modified Mohs micrographic surgery for periocular melanoma and melanoma in situ: long-term experience at Scripps Clinic.
    Shumaker PR; Kelley B; Swann MH; Greenway HT
    Dermatol Surg; 2009 Aug; 35(8):1263-70. PubMed ID: 19438663
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Basal cell carcinoma treated with Mohs surgery in Australia II. Outcome at 5-year follow-up.
    Leibovitch I; Huilgol SC; Selva D; Richards S; Paver R
    J Am Acad Dermatol; 2005 Sep; 53(3):452-7. PubMed ID: 16112352
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of narrow-margin excision of well-demarcated primary facial basal cell carcinomas.
    Kimyai-Asadi A; Alam M; Goldberg LH; Peterson SR; Silapunt S; Jih MH
    J Am Acad Dermatol; 2005 Sep; 53(3):464-8. PubMed ID: 16112354
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extramammary Paget's disease: surgical treatment with Mohs micrographic surgery.
    Hendi A; Brodland DG; Zitelli JA
    J Am Acad Dermatol; 2004 Nov; 51(5):767-73. PubMed ID: 15523356
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mohs micrographic surgery is accurate 95.1% of the time for melanoma in situ: a prospective study of 167 cases.
    Bene NI; Healy C; Coldiron BM
    Dermatol Surg; 2008 May; 34(5):660-4. PubMed ID: 18261099
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Direct Cost-Analysis of Mohs Micrographic Surgery and Traditional Excision for Basal Cell Carcinoma at Initial Margin Clearance.
    Sebaratnam DF; Choy B; Lee M; Paver R; Fernández Peñas P
    Dermatol Surg; 2016 May; 42(5):633-8. PubMed ID: 27110895
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 508.